middle.news
Aroa Biosurgery Posts First Positive Cash Flow Since ASX Listing, Eyes Strong FY25 Growth
7:03pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Aroa Biosurgery Posts First Positive Cash Flow Since ASX Listing, Eyes Strong FY25 Growth
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
First positive operating cash flow of NZ$1.2 million since ASX listing
Strong cash balance of NZ$21.9 million and debt-free status
FY25 revenue guidance raised to NZ$81-84 million, up 17-22% on FY24
Peer-reviewed study confirms efficacy of Myriad products in complex limb salvage
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Aroa Biosurgery (ASX:ARX)
OPEN ARTICLE